Artificial Intelligence Increases Diabetic Eye Exams in Youth With Diabetes

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Jan. 16, 2024 -- For youth with diabetes, an autonomous artificial intelligence diabetic eye exam at the point of care is associated with increased diabetic eye exam completion rates within six months, according to a study published online Jan. 11 in Nature Communications.

Risa M. Wolf, M.D., from the Johns Hopkins School of Medicine in Baltimore, and colleagues conducted a parallel randomized controlled trial involving youth aged 8 to 21 years with type 1 and type 2 diabetes. Participants were randomly assigned to an autonomous artificial intelligence diabetic eye exam at the point of care (intervention) or scripted eye care provider referral and education (control) in an academic pediatric diabetes center (81 and 83 participants, respectively).

The researchers found that the rate of diabetic eye exam completion within six months was significantly higher in the intervention group versus control group (100 versus 22 percent). An abnormal result occurred in 25/81 participants in the intervention arm, 64 percent of whom completed follow-through with eye care providers compared with 22 percent in the control arm.

"With AI technology, more people can get screened, which could then help identify more people who need follow-up evaluation," Wolf said in a statement. "If we can offer this more conveniently at the point of care with their diabetes doctor, then we can also potentially improve health equity, and prevent the progression of diabetic eye disease."

Two authors disclosed ties to the pharmaceutical industry; relevant patents and patent applications were assigned to the University of Iowa and Digital Diagnostics.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-17 22:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords